Andreas Fintelmann joins ABX-CRO as Managing Director

Andreas Fintelmann, leading radiopharmaceutical and precursor industry expert and executive joins ABX-CRO as managing director to support the further global expansion and growth of ABX-CRO.

Andreas Fintelmann states “I am delighted to join ABX-CRO and reunite with Andreas Kluge again, re-establishing a most productive professional friendship, which has substantially contributed to the development of the radiopharmaceutical space, as we know it today”

Andreas Kluge adds “with Andreas on board, ABX-CRO further strengthens its globally unique radiopharmaceutical development portfolio, underpinning our ambition to be the comprehensive reference service provider for the era of radiopharmaceutical molecular medicine”.